Idiopathic Pulmonary Fibrosis: Treating a Mystery
By: Svetlana Akbasheva, Section Editor - Idiopathic pulmonary fibrosis (IPF) is a devastating condition in which the lungs become thick…
Even the FDA follows Kim!
By: Nancy Simon, PharmD Candidate 2016 - Many of you may have seen Kim Kardashian West’s Instagram posts – most…
Probiotics as a possible treatment antibiotic-associated diarrhea in the ICU
By: Holly Sokol, PharmD Candidate 2020 - Antibiotic-associated diarrhea (AAD) can occur due to antibiotics changing the elements of the…
New Treatment Option for Diabetic Retinopathy
By: Sylva Ohanian, Staff Writer - The FDA recently approved aflibercept (Eylea®) injection for the treatment of diabetic retinopathy (DR)…
Cytisine: Another Option for Smoking Cessation
By: Andrew Leong, Staff Writer - Quitting smoking greatly reduces the risk of many diseases such as lung cancer, coronary…
Aripiprazole (Abilify®) Approved
By: Sang Hyo Kim, Section Editor - On April 28, 2015, the U.S. Food and Drug Administration approved aripiprazole, the…
FDA Approves First Tissue Adhesive for Internal Use
By: Azia Tariq, Section Editor - The U.S. Food and Drug Administration (FDA) has approved TissuGlu®, the first tissue adhesive…
Should Pharmacists Provide Drugs for Lethal Injections?
By: Svetlana Akbasheva, Staff Editor - This March, both the International Academy of Compounding Pharmacists (IACP) and American Pharmacists Association…
Sodium Zirconium Cyclosilicate: A Novel Potassium Binder
By: Andrew Leong, Staff Writer - Hyperkalemia is defined as a serum potassium level of greater than 5.0 mmol/L.1 In…
Stiolto™ Respimat® Enters Market
By: Sylva Ohanian, Staff Writer - Chronic obstructive pulmonary disease (COPD) is a serious yet treatable lung disease, which affects…